Lv11
30 积分 2025-03-18 加入
MA12.03 FLAURA2: Resistance, and Impact of Baseline TP53 Alterations in Patients Treated With 1L Osimertinib ± Platinum-Pemetrexed
4小时前
已完结
EP.12D.04 Treatment Pattern and Clinical Outcome in Chinese NSCLC Patients with MET Alterationwho Had Disease Progressionon EGFR-TKIs
4小时前
已完结
Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non–Small Cell Lung Cancer with PIK3CA/PTEN Alterations
5小时前
已完结
PIKing up and AKTing on resistance mutations in osimertinib-treated EGFR-mutated NSCLC
6小时前
已完结
皖公网安备34019202002308
